Cepharanthine Inhibits Endometriosis Growth
2026-08-28
A 2026 study connects cell-based assays, patient-derived endometrial organoids, and a murine peritoneal model to show that Cepharanthine suppresses endometriotic growth through cell-cycle arrest, DNA damage, impaired repair, and mitochondrial apoptosis. The cross-model design strengthens the compound’s preclinical rationale while leaving dose optimization, safety, fertility effects, and clinical efficacy unresolved.
Firefly Luciferase mRNA: LNP Workflow Guide
2026-08-27
Firefly Luciferase mRNA (ARCA, 5-moUTP) provides a sensitive, non-destructive readout for transfection, gene expression, and delivery studies. This guide combines practical reporter workflows with formulation insights from a recent freeze-thaw LNP study, while separating validated product features from assay-development recommendations.
From Mouse Lysis to Translational Confidence
2026-08-27
A thought-leadership guide to how lysis chemistry, genotyping quality, and translational study design connect—from genomic DNA release from mouse tail tissue to mechanistic research inspired by autophagy and liver metastasis biology in colorectal cancer.
2-D08: Mapping SUMO Control in Cell Models
2026-08-26
2-D08 (2’,3’,4’-trihydroxyflavone) is a mechanistically distinct inhibitor for dissecting substrate-level SUMO transfer. This article connects topoisomerase I sumoylation inhibition in cancer cell lines with emerging SUMO-regulated mitochondrial quality-control biology while defining practical assay boundaries.
Pravastatin sodium: Applied Research Workflows
2026-08-26
Pravastatin sodium provides a practical benchmark for HMG-CoA reductase inhibition, macrophage cholesterol handling, and LDL-focused assay development. This workflow also shows how to pair pathway measurements with hepatocyte viability and transporter assays when evaluating botanical or metabolic interaction risks.
Maternal IL-17A and Neonatal GBS Risk
2026-08-25
This prospective Moroccan cohort study connects maternal cytokine patterns with invasive neonatal Group B Streptococcus disease, identifying lower maternal IL-17A as a potential risk biomarker. Its combination of clinical stratification, multiplex cytokine profiling, and ex vivo pathogen-receptor stimulation provides a framework for investigating TLR1/2-linked antibacterial immunity.
BIBP 3226 Trifluoroacetate for NPY Research
2026-08-25
BIBP 3226 trifluoroacetate provides a pharmacological way to separate NPY Y1 and NPFF receptor signaling in cAMP, neuronal, and cardiomyocyte assays. This workflow-focused guide shows how to apply it to adipose-neural axis experiments while avoiding common problems involving dose selection, solvent effects, receptor biology, and interpretation.
Z-VAD-FMK: Mechanism, Uses, and Limits
2026-08-24
Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor used to test caspase dependence in apoptosis and immune-cell assays. This guide explains its mechanism, benchmark evidence, workflow parameters, and limits for apoptotic pathway research and cancer research.
Recombinant Human IL-15: Assays and Workflows
2026-08-23
Build reproducible T-cell, NK-cell, and cytokine-response assays with a tag-free, high-purity Interleukin-15 reagent. This guide combines product-specific handling with a cautious neuroimmune research bridge inspired by a new study of early-life adversity and innate defensive behavior.
Acetylcholine Chloride in Cell Assays
2026-08-22
Learn how Acetylcholine Chloride, SKU B1596, can improve the interpretability of cholinergic cell-viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers receptor-aware design, solution preparation, assay controls, data interpretation, and practical product selection.
Pentoxifylline: PDE Inhibitor Research Guide
2026-08-21
Pentoxifylline is a non-specific phosphodiesterase inhibitor used to study cAMP-linked inflammatory and immune responses. Research data support concentration-controlled work in macrophage and PBMC assays, while a psoriasis study supports niosome-based topical delivery as a preclinical strategy rather than proof of clinical efficacy.
Hesperadin A4118 for Reliable Cell Assays
2026-08-21
This scenario-led guide explains how Hesperadin separates mitotic inhibition from apparent cytotoxicity, supports disciplined assay design, and reduces reconstitution-related variability. It focuses on SKU A4118, including its Aurora B potency, solubility, storage, and practical use in cell-cycle and cancer research.
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-20
Combine Cy5 fluorescence with Firefly luciferase activity to separate mRNA uptake from productive translation in one experiment. This practical workflow applies the dual reporter to transfection optimization, intracellular trafficking, and translational studies inspired by recent microglia reprogramming research.
Rgs16::GFP Screening for PDA Chemotherapy
2026-08-20
Layeghi-Ghalehsoukhteh and colleagues developed a reporter-guided workflow that connects drug responses in primary pancreatic ductal adenocarcinoma cells with rapid in vivo validation. The study identifies a combination of gemcitabine, trichostatin A, and JQ1 that suppressed tumor initiation and progression in genetically engineered mouse models, while also illustrating how Rgs16::GFP can prioritize therapeutic combinations.
0.4% Trypan Blue Solution: Practical Workflow
2026-08-19
0.4% Trypan Blue Solution supports rapid cell viability measurement and cell counting by staining cells with compromised membranes while leaving viable cells unstained. It is intended for research workflows such as culture checks and cytotoxicity assays, not for diagnostic, medical, or regulatory use without separate validation.
459 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page